2021 Maryland Legislative Priorities

Ensuring Access to Quality Care

  • Medication Access: ACS CAN will support legislation to prohibit mid-year changes to prescription drug coverage or out-of-pocket costs during the plan year. 
  • Biomarkers/Precision Medicine: ACS CAN will prioritize the education of policymakers about the role of biomarker testing in precision medicine which uses information about a person’s own genes or proteins to prevent, diagnose or treat diseases like cancer and can improve cancer treatment and survival.

Cancer Prevention and Early Detection

  • Breast and Cervical Cancer: ACS CAN will advocate to maintain funding for the state Breast and Cervical Cancer Diagnosis and Treatment Program (BCCDT) and the state Breast and Cervical Cancer Program (BCCP) at $13.2 million. The BCCDT program, administered by the Maryland Department of Health, provides breast and cervical cancer treatment services to low-income uninsured and underinsured women. The BCCP program provides breast and cervical cancer screening, diagnosis, and patient navigation services to women across the state. ​ 
  • Cancer Research, Screening, Detection and Treatment: ACS CAN will work to protect funding for local cancer screening, treatment, patient navigation programs and research at Maryland’s renowned academic medical centers (John Hopkins University and the University of Maryland).

Reducing the Toll of Tobacco

  • Tobacco Taxes and Tobacco Prevention and Cessation Funding: ACS CAN will advocate to overturn Governor Hogan’s veto on HB 732—in which, includes line items for increases on the State’s cigarette tax by $1.75 per pack with an increase in the tax on some other tobacco products, including taxing electronic smoking devices for the first time. Increasing the price of cigarettes and all other tobacco products through regular and significant tobacco tax increases helps to keep kids from starting to use tobacco and helps adults quit.  The legislation also includes line items for $18.25 million of the revenue from the tobacco taxes to sustain evidence-based, statewide tobacco use prevention and cessation programs. ACS CAN will also work to protect this additional funding. This legislation is projected to bring in $95.76 million in State Revenue.